Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " September 24, 2008":" October 24, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated
Has Results
Phase IIB Pilot of Atazanavir + Raltegravir
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Raltegravir;   Drug: Ritonavir;   Drug: Tenofovir/Emtricitabine
22 Completed Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
Condition: HIV
Interventions: Drug: Abacavir;   Drug: Darunavir/ritonavir;   Drug: Raltegravir
23 Terminated NNRTI/PI Toxicity Switch to Darunavir Study
Condition: HIV
Interventions: Drug: darunavir;   Drug: ritonavir
24 Completed Influenza Vaccine in HIV
Conditions: Influenza;   HIV
Intervention: Biological: Fluviral
25 Completed
Has Results
A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)
Condition: Human Immunodeficiency Virus
Intervention: Drug: Comparator: raltegravir
26 Completed Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue
Condition: HIV/AIDS
Intervention: Drug: Maraviroc
27 Completed A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
Conditions: HIV;   AIDS
Intervention: Drug: Raltegravir (Isentress®)
28 Completed ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
Condition: HIV-1
Interventions: Drug: Truvada + Kaletra;   Drug: Kivexa + Kaletra
29 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
30 Completed The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet
Conditions: Pregnancy;   HIV
Intervention: Drug: Kaletra
31 Completed VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.
Conditions: Hepatitis C;   Telaprevir;   HIV
Intervention: Drug: Telaprevir; Darunavir; Ritonavir; Fosamprenavir
32 Withdrawn Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
Conditions: Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Depression;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Psychosocial Effects of Cancer and Its Treatment;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Other: medical chart review;   Other: questionnaire administration;   Procedure: psychosocial assessment and care

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Study has passed its completion date and status has not been verified in more than two years.